Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.72 |
| ▸ | TSHR | P16473 | 4/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.72 |
| ▸ | HPGD | P15428 | 3/20 | 0.72 |
| ▸ | POLB | P06746 | 3/20 | 0.72 |
| ▸ | KCNA2 | P16389 | 1/20 | 0.71 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.71 |
| ▸ | KCNA3 | P22001 | 6/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | ALDH1A2 | O94788 | 2/20 | 0.49 |
| ▸ | ALDH2 | P05091 | 2/20 | 0.49 |
| ▸ | ALDH1B1 | P30837 | 2/20 | 0.49 |
| ▸ | ALDH1A3 | P47895 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7000338 | 0.99 | ALDH1A1 (0.76) | ALDH1A1KDM4ETSHRHSD17B10HPGD | |
| SCHEMBL11380969 | 0.84 | ALDH1A1 (1.00) | ALDH1A1KDM4ETSHRHSD17B10HPGD | |
| SCHEMBL1002900 | 0.82 | ALDH1A1 (1.00) | ALDH1A1KDM4ETSHRHSD17B10HPGD | |
| SCHEMBL11382405 | 0.76 | ALDH1A1 (0.79) | ALDH1A1KDM4ETSHRHSD17B10HPGD | |
| SCHEMBL7000371 | 0.75 | MAOA (0.60) | ALDH1A1KDM4ETSHRHSD17B10HPGD | |
| Hydrochloric Acid SCHEMBL7000954 | 0.74 | MAOA (0.59) | ALDH1A1KDM4ETSHRHSD17B10HPGD | |
| SCHEMBL19248241 | 0.73 | ALDH1A1 (0.67) | ALDH1A1KDM4ETSHRHSD17B10HPGD | |
| SCHEMBL18074127 | 0.71 | KCNA3 (0.79) | ALDH1A1KDM4ETSHRHSD17B10HPGD | |
| SCHEMBL18074006 | 0.71 | KCNA3 (1.00) | ALDH1A1KDM4ETSHRHSD17B10HPGD | |
| SCHEMBL11376434 | 0.71 | ALDH1A1 (0.68) | ALDH1A1KDM4ETSHRHSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1032265-B1 | NEW PSORALENS FOR PATHOGEN INACTIVATION | CERUS CORP (US) | 2003-10-29 | — | — | EP | disclosed |
| US-20030082510-A1 | Psoralens for pathogen inactivation | CERUS CORPORATION (US) | 2003-05-01 | — | — | US | disclosed |
| US-6455286-B1 | MIXING PSORALEN COMPOUND OF DEFINED STRUCTURE WITH BIOLOGICAL COMPOSITION SUCH AS BLOOD OR PLATELETS, THEN PHOTOACTIVATING COMPOUND TO DEACTIVATE PATHOGEN | CERUS CORPORATION | 2002-09-24 | — | — | US | disclosed |
| EP-1032265-A4 | NEW PSORALENS FOR PATHOGEN INACTIVATION | CERUS CORP (US) | 2001-05-30 | — | — | EP | disclosed |
| US-6133460-A | HAVE PRIMARY AMINO SUBSTITUTIONS ON THE 3-, 4-, 5-, AND 8-POSITIONS OF THE PSORALEN WHICH PERMIT BINDING TO NUCLEIC ACID OF PATHOGENS; CONDITIONS THAT PHOTOACTIVATE THESE PSORALENS RESULT IN INACTIVATION OF PATHOGENS WHICH CONTAIN NUCLEIC ACID | CERUS CORPORATION (US) | 2000-10-17 | — | — | US | disclosed |
| EP-1032265-A1 | NEW PSORALENS FOR PATHOGEN INACTIVATION | Cerus Corporation (US) | 2000-09-06 | — | — | EP | disclosed |
| WO-1999026476-A1 | NEW PSORALENS FOR PATHOGEN INACTIVATION | CERUS CORPORATION (US) | 1999-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030082510-A1 | Psoralens for pathogen inactivation | BPGM, XPA, RAD50 | ALDH1A1 1468/4885KDM4E 3035/4885TSHR 3453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.